Amylyx Pharmaceuticals (AMLX) Inventory (2022 - 2023)
Amylyx Pharmaceuticals (AMLX) posted Inventory of $38.3 million for Q4 2023, up 18.38% on a QoQ basis from $32.4 million in Q3 2023, and up 292.29% year-over-year from $9.8 million in Q4 2022.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Inventory (2022 - 2023) Analysis & Trends
Amylyx Pharmaceuticals has reported Inventory for 2 years, with the latest figure at $38.3 million in Q4 2023.
- On a quarterly basis, Inventory rose 292.29% year-over-year to $38.3 million in Q4 2023; TTM through Dec 2023 was $38.3 million, a 292.29% increase from a year earlier, with the FY2023 full-year figure at $38.3 million, up 292.29% from the prior year.
- Inventory was $38.3 million for Q4 2023 at Amylyx Pharmaceuticals, up from $32.4 million in the prior quarter.
- The five-year high for Inventory was $38.3 million in Q4 2023, with the low at $563000.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.20 Bn | 198.21 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 181.83 Bn | 178.65 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 132.47 Bn | 124.61 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.56 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.40 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 54.65 Bn | 49.51 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 31.42 Bn | 30.13 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Roivant Sciences | 30.21 Bn | 30.21 Bn | 1.16 Mn | - |
| 10 | Amylyx Pharmaceuticals | 3.68 Bn | 3.68 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 38.32 Mn |
| Sep 30, 2023 | 32.37 Mn |
| Jun 30, 2023 | 24.86 Mn |
| Mar 31, 2023 | 13.08 Mn |
| Dec 31, 2022 | 9.77 Mn |
| Sep 30, 2022 | 563,000.00 |